Popular Articles
Cellulite Cream

Kenya Malaria Study Shows One-Third Of Patients Receive ACTs
Just about one-third of people seeking malaria treatment in Kenya received the recommended artemisinin-based combination therapies (ACTs) and some people are being treated with ineffective drugs like chloroquine, which was phased out almost 10 years ago, according to the recently launched 2007 Kenya Malaria Indicator Survey - the country"s "first ever comprehensive malaria study," the Daily Nation reports (Gathura/Cheboi, 6/30).
generic viagra online
Somaxon Resubmits New Drug Application For Silenor(R) (Doxepin) For The Treatment Of Insomnia
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Silenor® (doxepin) for the treatment of insomnia.
News of the day
NexMed Announces Decision For Anti-Fungal Product
NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT® technology, announced the mutual decision with Novartis to terminate the licensing agreement for NM100060, a topically-applied treatment for onychomycosis, commonly known as nail fungus. NexMed entered into the exclusive, worldwide agreement with Novartis in September 2005, under which Novartis assumed all clinical development, regulatory, manufacturing and commercialization responsibilities for NM100060.
Nutrition

British Dental Association Launches Good Practice Scheme For Scotland

The BDA is pleased to announce the expansion of its highly successful Good Practice Scheme (GPS) with the launch of the Good Practice Scheme Scotland (GPS Scotland) at this year"s British Dental Conference and Exhibition in Glasgow. This dedicated Scottish version incorporates standards criteria specific to Scottish practices. As with the original GPS, GPS Scotland provides both dentists and patients alike with a clear standard of practice, complementing the NHS Quality Improvement Standards which apply to all practices. The Scheme also integrates new requirements in oral health assessment, decontamination, and sedation and emergency dental care, as well as links to further guidance. The new Scheme gives patients in Scotland reassurance that the entire practice team is compliant with a high standard of care and sound clinical governance. Successful completion of the Scheme enables members to enjoy improved communication, teamwork and practice, and patients can rely upon up-to-date knowledge of the legal and ethical requirements necessary to achieve the Scheme"s assurance of quality. On launching GPS Scotland, BDA Executive Board chair Susie Sanderson, said: "The expansion of the Good Practice Scheme with this new Scottish version builds upon the success and reputation of the Scheme since it began in 2001. GPS Scotland demonstrates the profession"s commitment to high standards of care and provides a Scotland-specific benchmark for quality assurance in dental practice." Becoming a GPS Scotland practice begins with completion and validation by assessors of achievement of the standard, leading to recognition as a BDA Good Practice. Membership renewal involves re-assessment every three years. A regional administrator supports and guides those going through the application process, helping them to comply with the requirements. Further details are available here. The British Dental Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):